The Tumor-Specific Expression of L1 Retrotransposons Independently Correlates with Time to Relapse in Hormone-Negative Breast Cancer Patients.
Enrico BerrinoUmberto MiglioSara Erika BellomoCarla DebernardiAlberto BragoniAnnalisa PetrelliEleonora NacchieroSilvia GiordanoFilippo MontemurroCaterina MarchioTiziana VenesioAnna SapinoPublished in: Cells (2022)
Overall, L1 reactivation identified BCs with aggressive features and patients with a worse clinical fate.